proposed a rigorous hypoxia-sensing CAR T cell system that achieves selective expression of a pan-ErbB-targeted CAR molecules within the TME in solid tumor characterized by the hypoxia environment, achieving a considerable anti-tumor efficacy without off-tumor toxicity (124). This evidence concerns the gene EGFR and neoplasm.